𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-445 Weekly docetaxel (TXT) with prolonged infusion (PI) of gemcitabine (GEM): A promising therapeutic option in patients with advanced, pretreated non-small cell lung cancer (NSCLC). A two stage SIMON designed phase II study

✍ Scribed by Antonelli, G.; Priolo, D.; Colina, P.; Vitale, F.; Ferrau, F.


Book ID
118573350
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
146 KB
Volume
49
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.